Atomistry » Fluorine » PDB 2fq9-2gtm » 2g0g
Atomistry »
  Fluorine »
    PDB 2fq9-2gtm »
      2g0g »

Fluorine in PDB 2g0g: Structure-Based Drug Design of A Novel Family of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography and in Vitro/in Vivo Biological Activities

Protein crystallography data

The structure of Structure-Based Drug Design of A Novel Family of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography and in Vitro/in Vivo Biological Activities, PDB code: 2g0g was solved by I.L.Lu, Y.H.Peng, C.F.Huang, Y.T.Lin, J.T.A.Hsu, S.Y.Wu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 20.00 / 2.54
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 56.419, 88.805, 58.258, 90.00, 89.99, 90.00
R / Rfree (%) 21.6 / 26.4

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Structure-Based Drug Design of A Novel Family of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography and in Vitro/in Vivo Biological Activities (pdb code 2g0g). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Structure-Based Drug Design of A Novel Family of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography and in Vitro/in Vivo Biological Activities, PDB code: 2g0g:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 2g0g

Go back to Fluorine Binding Sites List in 2g0g
Fluorine binding site 1 out of 2 in the Structure-Based Drug Design of A Novel Family of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography and in Vitro/in Vivo Biological Activities


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Structure-Based Drug Design of A Novel Family of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography and in Vitro/in Vivo Biological Activities within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F101

b:84.8
occ:1.00
F40 A:SP0101 0.0 84.8 1.0
C23 A:SP0101 1.3 82.7 1.0
C22 A:SP0101 2.3 81.5 1.0
C24 A:SP0101 2.4 82.3 1.0
C21 A:SP0101 3.6 82.7 1.0
C25 A:SP0101 3.7 81.6 1.0
CB A:ARG288 3.8 56.3 1.0
N A:SER289 3.9 51.0 1.0
OG A:SER289 4.0 47.5 1.0
C A:ARG288 4.0 53.8 1.0
C26 A:SP0101 4.1 81.5 1.0
O A:CYS285 4.1 65.1 1.0
CA A:SER289 4.3 49.6 1.0
O A:ARG288 4.3 52.2 1.0
CG2 A:ILE326 4.4 29.1 1.0
NE A:ARG288 4.4 58.4 1.0
CA A:ARG288 4.6 55.6 1.0
CG A:ARG288 4.6 59.0 1.0
CB A:SER289 4.8 49.4 1.0
S18 A:SP0101 5.0 85.3 1.0

Fluorine binding site 2 out of 2 in 2g0g

Go back to Fluorine Binding Sites List in 2g0g
Fluorine binding site 2 out of 2 in the Structure-Based Drug Design of A Novel Family of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography and in Vitro/in Vivo Biological Activities


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Structure-Based Drug Design of A Novel Family of Ppar Partial Agonists: Virtual Screening, X-Ray Crystallography and in Vitro/in Vivo Biological Activities within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F101

b:81.4
occ:1.00
F27 A:SP0101 0.0 81.4 1.0
C14 A:SP0101 1.3 78.8 1.0
C15 A:SP0101 2.3 78.6 1.0
C13 A:SP0101 2.4 78.7 1.0
CE2 A:TYR473 3.3 68.0 1.0
CD1 A:LEU465 3.4 70.9 1.0
CD1 A:LEU469 3.5 62.8 1.0
C16 A:SP0101 3.6 79.2 1.0
C12 A:SP0101 3.6 80.1 1.0
CG A:LEU465 3.8 71.7 1.0
OH A:TYR473 3.9 64.5 1.0
CZ A:TYR473 4.0 67.4 1.0
C11 A:SP0101 4.1 81.7 1.0
CD2 A:TYR473 4.2 67.2 1.0
CB A:LEU469 4.2 64.8 1.0
CB A:GLN286 4.3 63.5 1.0
CG A:LEU469 4.3 65.1 1.0
CB A:LEU465 4.6 70.8 1.0
CD2 A:LEU469 4.6 62.4 1.0
CA A:GLN286 4.6 63.4 1.0
CG A:GLN286 4.6 65.5 1.0
CD A:GLN286 4.7 66.0 1.0
NE2 A:GLN286 4.9 62.2 1.0
CD2 A:LEU465 5.0 75.2 1.0
OE1 A:GLN286 5.0 67.4 1.0

Reference:

I.L.Lu, C.F.Huang, Y.H.Peng, Y.T.Lin, H.P.Hsieh, C.T.Chen, T.W.Lien, H.J.Lee, N.Mahindroo, E.Prakash, A.Yueh, H.Y.Chen, C.M.Goparaju, X.Chen, C.C.Liao, Y.S.Chao, J.T.Hsu, S.Y.Wu. Structure-Based Drug Design of A Novel Family of Ppargamma Partial Agonists: Virtual Screening, X-Ray Crystallography, and in Vitro/in Vivo Biological Activities J.Med.Chem. V. 49 2703 2006.
ISSN: ISSN 0022-2623
PubMed: 16640330
DOI: 10.1021/JM051129S
Page generated: Wed Jul 31 14:27:55 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy